Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population

The cross-sectional BOLD study

Nathania A J B Cooksley, David Atkinson, Guy B. Marks, Brett G. Toelle, David Reeve, David P. Johns, Michael J. Abramson, Deborah L. Burton, Alan L. James, Richard Wood-Baker, E. Haydn Walters, A (Sonia) Buist, Graeme P. Maguire

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background and objective Mortality and hospital separation data suggest a higher burden of chronic obstructive pulmonary disease (COPD) in indigenous than non-indigenous subpopulations of high-income countries. This study sought to accurately measure the true prevalence of post-bronchodilator airflow obstruction and forced vital capacity reduction in representative samples of Indigenous and non-Indigenous Australians. Methods This study applies cross-sectional population-based survey of Aboriginal and non-Indigenous residents of the Kimberley region of Western Australia aged 40 years or older, following the international Burden Of Lung Disease (BOLD) protocol. Quality-controlled spirometry was conducted before and after bronchodilator. COPD was defined as Global initiative for chronic Obstructive Lung Disease (GOLD) Stage 2 and above (post-bronchodilator forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC) ratio 1-

Original languageEnglish (US)
Pages (from-to)766-774
Number of pages9
JournalRespirology
Volume20
Issue number5
DOIs
StatePublished - Jul 1 2015

Fingerprint

Bronchodilator Agents
Vital Capacity
Chronic Obstructive Pulmonary Disease
Lung Diseases
Population
Western Australia
Spirometry
Forced Expiratory Volume
Hospital Mortality
Cross-Sectional Studies

Keywords

  • chronic obstructive pulmonary disease
  • indigenous population
  • race
  • respiratory function test
  • vital capacity

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Cooksley, N. A. J. B., Atkinson, D., Marks, G. B., Toelle, B. G., Reeve, D., Johns, D. P., ... Maguire, G. P. (2015). Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: The cross-sectional BOLD study. Respirology, 20(5), 766-774. https://doi.org/10.1111/resp.12482

Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population : The cross-sectional BOLD study. / Cooksley, Nathania A J B; Atkinson, David; Marks, Guy B.; Toelle, Brett G.; Reeve, David; Johns, David P.; Abramson, Michael J.; Burton, Deborah L.; James, Alan L.; Wood-Baker, Richard; Walters, E. Haydn; Buist, A (Sonia); Maguire, Graeme P.

In: Respirology, Vol. 20, No. 5, 01.07.2015, p. 766-774.

Research output: Contribution to journalArticle

Cooksley, NAJB, Atkinson, D, Marks, GB, Toelle, BG, Reeve, D, Johns, DP, Abramson, MJ, Burton, DL, James, AL, Wood-Baker, R, Walters, EH, Buist, AS & Maguire, GP 2015, 'Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: The cross-sectional BOLD study', Respirology, vol. 20, no. 5, pp. 766-774. https://doi.org/10.1111/resp.12482
Cooksley, Nathania A J B ; Atkinson, David ; Marks, Guy B. ; Toelle, Brett G. ; Reeve, David ; Johns, David P. ; Abramson, Michael J. ; Burton, Deborah L. ; James, Alan L. ; Wood-Baker, Richard ; Walters, E. Haydn ; Buist, A (Sonia) ; Maguire, Graeme P. / Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population : The cross-sectional BOLD study. In: Respirology. 2015 ; Vol. 20, No. 5. pp. 766-774.
@article{e265bafdf6144ea5b9220d0474165468,
title = "Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: The cross-sectional BOLD study",
abstract = "Background and objective Mortality and hospital separation data suggest a higher burden of chronic obstructive pulmonary disease (COPD) in indigenous than non-indigenous subpopulations of high-income countries. This study sought to accurately measure the true prevalence of post-bronchodilator airflow obstruction and forced vital capacity reduction in representative samples of Indigenous and non-Indigenous Australians. Methods This study applies cross-sectional population-based survey of Aboriginal and non-Indigenous residents of the Kimberley region of Western Australia aged 40 years or older, following the international Burden Of Lung Disease (BOLD) protocol. Quality-controlled spirometry was conducted before and after bronchodilator. COPD was defined as Global initiative for chronic Obstructive Lung Disease (GOLD) Stage 2 and above (post-bronchodilator forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC) ratio 1-",
keywords = "chronic obstructive pulmonary disease, indigenous population, race, respiratory function test, vital capacity",
author = "Cooksley, {Nathania A J B} and David Atkinson and Marks, {Guy B.} and Toelle, {Brett G.} and David Reeve and Johns, {David P.} and Abramson, {Michael J.} and Burton, {Deborah L.} and James, {Alan L.} and Richard Wood-Baker and Walters, {E. Haydn} and Buist, {A (Sonia)} and Maguire, {Graeme P.}",
year = "2015",
month = "7",
day = "1",
doi = "10.1111/resp.12482",
language = "English (US)",
volume = "20",
pages = "766--774",
journal = "Respirology",
issn = "1323-7799",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population

T2 - The cross-sectional BOLD study

AU - Cooksley, Nathania A J B

AU - Atkinson, David

AU - Marks, Guy B.

AU - Toelle, Brett G.

AU - Reeve, David

AU - Johns, David P.

AU - Abramson, Michael J.

AU - Burton, Deborah L.

AU - James, Alan L.

AU - Wood-Baker, Richard

AU - Walters, E. Haydn

AU - Buist, A (Sonia)

AU - Maguire, Graeme P.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Background and objective Mortality and hospital separation data suggest a higher burden of chronic obstructive pulmonary disease (COPD) in indigenous than non-indigenous subpopulations of high-income countries. This study sought to accurately measure the true prevalence of post-bronchodilator airflow obstruction and forced vital capacity reduction in representative samples of Indigenous and non-Indigenous Australians. Methods This study applies cross-sectional population-based survey of Aboriginal and non-Indigenous residents of the Kimberley region of Western Australia aged 40 years or older, following the international Burden Of Lung Disease (BOLD) protocol. Quality-controlled spirometry was conducted before and after bronchodilator. COPD was defined as Global initiative for chronic Obstructive Lung Disease (GOLD) Stage 2 and above (post-bronchodilator forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC) ratio 1-

AB - Background and objective Mortality and hospital separation data suggest a higher burden of chronic obstructive pulmonary disease (COPD) in indigenous than non-indigenous subpopulations of high-income countries. This study sought to accurately measure the true prevalence of post-bronchodilator airflow obstruction and forced vital capacity reduction in representative samples of Indigenous and non-Indigenous Australians. Methods This study applies cross-sectional population-based survey of Aboriginal and non-Indigenous residents of the Kimberley region of Western Australia aged 40 years or older, following the international Burden Of Lung Disease (BOLD) protocol. Quality-controlled spirometry was conducted before and after bronchodilator. COPD was defined as Global initiative for chronic Obstructive Lung Disease (GOLD) Stage 2 and above (post-bronchodilator forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC) ratio 1-

KW - chronic obstructive pulmonary disease

KW - indigenous population

KW - race

KW - respiratory function test

KW - vital capacity

UR - http://www.scopus.com/inward/record.url?scp=84931562046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931562046&partnerID=8YFLogxK

U2 - 10.1111/resp.12482

DO - 10.1111/resp.12482

M3 - Article

VL - 20

SP - 766

EP - 774

JO - Respirology

JF - Respirology

SN - 1323-7799

IS - 5

ER -